Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Search Results

Your search returned 1870 record(s).

Page 140 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:

  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1391 8.6 months Newly diagnosed GBM 5 Biologic therapy
Cleveland Clinic United States 5/2010
Treatment Details: Patients: This phase 2 study involved 27 newly diagnosed glioblastoma patients with a median age of 52 years; 63% were male. Treatment: Patients were treated with radiation therapy, che
1392 8.5 months Metastatic urothelial carcinoma 5 Biologic therapy
University of Chicago United States 4/2014
Treatment Details: Patients: This phase 2 study involved 50 advanced or metastatic urothelial cancer patients who had received previous chemotherapy. The median patient age was 68.5 years and 80% were male.
1393 8.5 months Advanced melanoma 5 Biologic therapy
Cambridge Biomedical Research Centre United Kingdom 7/2011
Treatment Details: Patients: This phase II study involved 83 advanced melanoma patients who were not previously treated with chemotherapy. The median patient age was 56 years and 60% were male. Treatment:
1394 8.5 months Advanced NSCLC 5 Biologic therapy
National Cancer Center Korea 4/2012
Treatment Details: Patients: This phase 3 study involved 617 previously treated advanced non-small-cell lung cancer patients.. The median patient age was 60 years and 47% were male. Treatment: Patients w
1395 8.5 months Malignant Pleural Mesothelioma 4 Chemotherapy
The University of Texas M.D. Anderson Cancer Center United States 8/2000
Treatment Details: Patients: This Phase II study involved 24 patients with malignant pleural mesothelioma Treatment: The treatment consisted of the administration of the drug Doxil. Toxicity: Toxiciti
1396 8.5 months Recurrent or progressive malignant glioma 4 Chemotherapy
UCLA School of Medicine United States 5/2003
Treatment Details: Patients: This study involved 35 patients with progressive or recurrent malignant gliomas. Twenty-six had glioblastoma multiforme and 9 had various types of anaplastic gliomas. Treatmen
1397 8.5 months Newly diagnosed GBM Radiation
University of California San Francisco United States 1/2001
Treatment Details: Patients: This study included 231 patients with newly diagnosed glioblastoma multiforme. (Six patients were later determined to have a gliosarcoma.) The patients were divided into four tre
1398 8.5 months Recurrent Ovarian cancer 3 Biologic therapy
Vancover Cancer Center Canada 11/2005
Treatment Details: Patients: This pilot phase II study involved thirteen women with a mean age of 59.1 with recurrent stage III or IV ovarian cancer. Those enrolled in the study had an average of 2.5 prior c
1399 8.5 months metastatic melanoma 4 Chemotherapy
Cross Cancer Institute Canada 9/2006
Treatment Details: Patients: This phase II trial involved 15 patients with advanced malignant melanoma. The median age was 62 years, ranging from 29-86. Most had received no prior therapy for metastatic dis
1400 8.5 months Advanced NSCLC 5 Biologic therapy
University of Turin Italy 11/2009
Treatment Details: Patients: This phase 2 study involved 47 patients with advanced non-small cell lung cancer. Their median age was 60, ranging from 37 to 81 years of age. There were 27 men and 20 women.
Page 140 of 187  | Previous Page  | Next Page